AGA,FAGA
Conditions
Interventions
None listed
Sponsors
Medical Corporation TMC. Tokyo Memorial Clinic
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Japanese men and women between the ages of 18 and 60 at the time of consent. 2. Patients who wish to undergo PRP therapy of their own volition. 3. Patients who meet the following criteria according to hair loss classification Men with thinning hair Hamilton-Norwood Scale I-IV Female with thinning hair Ludwig Scale I-1 to II-2 4. Patients who have given written consent to participate in this study
Exclusion criteria
Exclusion criteria: 1. Patients with non-patterned alopecia and scarring alopecia 2. Patients with a history of hypersensitivity to concomitant medications 3. Patients with a history of bleeding disorders 4. Patients taking anticoagulants (aspirin, warfarin, heparin) 5. Patients with active local infection 6. Patients with keloid tendency on the scalp 7. Patients with a history of psoriasis, lichen planus, or vitiligo 8. Patients who are participating in other clinical trials or who have been participating in such trials for less than 6 months. 9. Other patients who are judged by the principal investigator or subinvestigator to be inappropriate to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Appearance of the parietal area and hairline before and 6 months after treatment | — |
Countries
Japan
Contacts
Public ContactHiromu Katsuta
Re-Life.inc Clinical Development Division
Outcome results
None listed